TransCelerate BioPharma Inc. is a non-profit organization with a mission to collaborate across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high-quality delivery of new medicines.

Curious about the latest happenings at TransCelerate? Check out the newest edition of our Pulse on Progress newsletter! This issue is chock full… of insights from the DIA 2024 Global conference, updates on volunteer and staff activities, exciting solution launches, and other announcements.

Gilead Sciences, Inc. (Gilead), a leading biopharmaceutical company that has achieved breakthroughs in medicine for more than three decades, has joined TransCelerate as its newest member.

TransCelerate and ACRO co-created an infographic highlighting key changes to the risk management elements within Good Clinical Practice. It aims to allow the R&D industry to easily identify the impact to their process and how to react for efficient ICH E6 (R3) implementation.

The TransCelerate Site Qualification and Training (SQT) Initiative has developed a Mutual Recognition (MR) Program for ICH E6 Good Clinical Practice (GCP) Training, targeted to investigator site personnel. Our GCP Mutual Recognition program was created to reduce redundant training and hours spent by investigators who need to complete the same training if they work with multiple sponsors.

TransCelerate Member Companies have translated select solutions for potential use within the broader global community. Current translations include solutions concerning Common Protocol Template, Site Qualification & Training, Quality Management Systems and Patient Experience.